Merck to bolster cancer drug portfolio with VelosBio $2.75 billion deal - Reuters

Reuters | Nov. 5, 2020, 6:43 a.m. | Original
Merck to bolster cancer drug portfolio with VelosBio $2.75 billion deal Reuters
Airbnb to make IPO filing public next week despite COVID-19 surge: sources - Reuters Denmark's mink cull a 'black day' for farmers, tighter COVID lockdown planned - Reuters